Citation Impact
Citing Papers
Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning
2006
Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines
2010
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Extracapsular invasion of lymph node metastasis
1999
Total versus subtotal thyroidectomy. Arguments, approaches, and recommendations.
1990
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Differentiated Thyroid Carcinoma with Distant Metastases: Probability of Survival and Its Predicting Factors
2007
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis
2007
Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients
2000
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
2004
Malignant pheochromocytoma: current status and initiatives for future progress
2004
Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis
1996
Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
1988
Follicular thyroid carcinoma
2002
Thyroid cancer: The case for total thyroidectomy
1988
The management of advanced thyroid cancer
2004
Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer
1992
Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients
2004
Pheochromocytomas and paragangliomas: assessment of malignant potential
2011
Differentiated thyroid cancer presenting initially with distant metastasis
1997
Prognostic Factors in Well-Differentiated Follicular-Derived Carcinoma and Medullary Thyroid Carcinoma
2001
Thyroid cancer
2016 Standout
Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed
2001
Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma
2003
Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma
1999
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
2008
Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables
1996
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin‐stimulated intravenous calcitonin sampling followed by targeted surgery
2007
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
2000
Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma
2006
Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
2002
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Prognostic factors and risk group analysis in follicular carcinoma of the thyroid
1995
Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid Cancer
1997
Pulmonary metastases in children and young adults with differentiated thyroid cancer
1993
Outcome of Palliative Embolization of Bone Metastases in Differentiated Thyroid Carcinoma
2003
Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer
2003
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients
2000
131 I Therapy for Elevated Thyroglobulin Levels
1997
Elevated Serum Procalcitonin Levels in Patients with Melioidosis
1995
Degree of Thyrotropin Suppression in Differentiated Thyroid Cancer without Recurrence or Metastases
1999
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
2000
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
1994 Standout
Medullary Thyroid Cancer
1995
Well-differentiated thyroid cancer
1994
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Understanding Catecholamine Metabolism as a Guide to the Biochemical Diagnosis of Pheochromocytoma
2001
Long-term Course of Patients with Persistent Hypercalcitoninemia After Apparent Curative Primary Surgery for Medullary Thyroid Carcinoma
1990
Operative and Postoperative Management of the Patient with Follicular and Hurthle Cell Carcinoma: Do they Differ?
1995
Follicular thyroid carcinoma: Histology and prognosis
2004
Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma
2001
Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma1
1998
Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma
2004
High serum procalcitonin concentrations in patients with sepsis and infection
1993 Standout
The role of local treatment in the cure of cancer
1992
Follicular Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome
1991
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
2003
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations
1993
Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas
2003 Standout
A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A
1997
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
2006
Changes in Clinical Presentation, Management and Outcome in 1348 Patients with Differentiated Thyroid Carcinoma: Experience in a Single Institute in Hong Kong, 1960–2000
2003
Mixed medullary‐papillary carcinoma of the thyroid: Report of a case and review of the literature
2009
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Embolization of Hepatic and Adrenal Metastasis to Treat Cushing’s Syndrome Associated with Medullary Thyroid Carcinoma: A Case Report
2007
Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma
1995
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local Control
1996
External-beam radiation therapy in the treatment of differentiated thyroid cancer
1999
Papillary and Follicular Thyroid Carcinoma
1998
Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma
2000
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole‐body scan: comparative study
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography
2003
Value of external irradiation for locally advanced papillary thyroid cancer
2003
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
2000
Papillary Thyroid Carcinoma
1998
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine
1995
External Beam Radiation Therapy for Thyroid Cancer
2008
Microcarcinoma of the thyroid gland
1998
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
2009
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
2004
Anti‐carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
2003
Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement
2005
Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma
2002
TheRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
1996
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Advances in the management of hereditary medullary thyroid cancer
2004
Somatostatin receptor imaging in persistent medullary thyroid carcinoma
1995
Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A
1998
Role of Neck Ultrasonography in the Follow-up of Patients Operated on for Thyroid Cancer
1995
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
2003
Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer
1995
Radioiodine Treatment for Differentiated Thyroid Cancer
2000
Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
1997
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
2004
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Serum Tg—A Sensitive Marker of Thyroid Abnormalities and Iodine Deficiency in Epidemiological Studies
2001
Treatment of medullary thyroid carcinoma: an update.
2001
Calcitonin levels in normal individuals with new highly sensitive chemiluminescent enzyme immunoassay
1998
Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy?
2002
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
2004
Clinical Presentations and Treatment for 74 Occult Thyroid Carcinoma
1996
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
1990 Standout
Expression of the Na+/I−Symporter Gene in Human Thyroid Tumors: A Comparison Study with Other Thyroid-Specific Genes1
1999
Survival and Death Causes in Differentiated Thyroid Carcinoma
2006
Management of the patient with progressive radioiodine non-responsive disease
1999
Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma
2001
Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation
2000
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake
2009
Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid
2003
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
2011
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Fièvre et tumeur solide : valeur diagnostique de la procalcitonine et de la protéine C réactive
2001
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Radioiodine in the Treatment of Thyroid Cancer
2007
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients
2003
Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies
2006
Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
2000
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement
2007
Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid Carcinoma
2000
Clinical use of recombinant human TSH in thyroid cancer patients
2000
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
1996
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy
2002
Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
2002
Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma Patients
2007 Standout
Hypercalcitoninemia in a Sporadic Asymptomatic Neuroendocrine Tumor of the Pancreatic Tail
2000
Cytotoxic Effects of Carboplatinum and Epirubicin in the Setting of an Elevated Serum Thyrotropin for Advanced Poorly Differentiated Thyroid Cancer
2002
Results of postoperative radiation therapy in medullary carcinoma of the thyroid: A retrospective study by the French Federation of Cancer Institutes - The Radiotherapy Cooperative Group
1992
The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-d -Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome
2004
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
2001
Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients
1997
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
1998 Standout
Medullary thyroid carcinoma
2004
SERUM THYROGLOBULIN MEASUREMENT
2001
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma
2002
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma
2016
Cushing's syndrome
2006 Standout
Surveillance of patients to detect recurrent thyroid carcinoma
1999
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.
2008
Differentiated thyroid carcinoma: Comparison between papillary and follicular carcinoma in a single institute
2002
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
2003
Prognostic factors for thyroid carcinoma
1997
Bone metastases from differentiated thyroid carcinoma
2008
A census of human cancer genes
2004 Standout
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
2004
Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment
2004
Testicular dose and fertility in men following I131 therapy for thyroid cancer
2002
Differentiated Thyroid Cancer: Determinants of Disease Progression in Patients <21 Years of Age at Diagnosis
1998
Comparison of Procalcitonin, sCD14 and Interleukin-6 Values in Septic Patients
2000
The surgical treatment of medullary thyroid carcinoma
1999
The value of plasma markers for the clinical behaviour of phaeochromocytomas
2002
Papillary and follicular thyroid cancer
1987
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
2000
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma
1999
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging
2003
Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
2008
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
1998
Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?
2004
131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
1996
Follow-Up of Low Risk Patients with Papillary Thyroid Cancer: Role of Neck Ultrasonography in Detecting Lymph Node Metastases
2004
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
2006
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Testicular function after radioiodine therapy for thyroid carcinoma
2000
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer
1992
Thyroid cancer management
1995
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
2012
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer
2002
Differentiated Thyroid Carcinoma in Childhood: Long Term Follow-Up of 72 Patients
1987
Benign and Malignant Thyroid Nodules: US Differentiation—Multicenter Retrospective Study
2008 Standout
Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis
2000
Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma
2002
The Relative Frequency in Which Empiric Dosages of Radioiodine Would Potentially Overtreat or Undertreat Patients Who Have Metastatic Well-Differentiated Thyroid Cancer
2006
Bone Metastases from Thyroid Carcinoma: Clinical Characteristics and Prognostic Variables in One Hundred Forty-Six Patients
2000
Recombinant Human Thyrotropin-Assisted Radioiodine Therapy for Patients with Metastatic Thyroid Cancer Who Could Not Elevate Endogenous Thyrotropin or Be Withdrawn from Thyroxine
2006
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Papillary Thyroid Carcinomas with Lung Metastases
2004
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma
2009
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Sequential Follow-up of Serum Thyroglobulin and Whole Body Scan in Thyroid Cancer Patients without Initial Metastasis
2006
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma
2005
Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature
2005
Resistance of [ 18 F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
2001
Multidisciplinary Treatment and Survival of Patients with Vertebral Metastases from Thyroid Carcinoma
2011
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
2007
Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis
2007
Characteristics of Follicular Cell-Derived Thyroid Carcinomas Occurring After External Radiation Exposure: Results of a Case Control Study Nested in a Cohort
2002
Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation
2010
Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases
2001
The Role of Radiotherapy in the Management of Elevated Calcitonin After Surgery for Medullary Thyroid Cancer
2001
Distant metastases in papillary thyroid cancer.A review of 91 patients
1988
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
1994
Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
1995
Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.
1993
Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.
2001
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
1994
Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases
1999
Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid
1988 StandoutNobel
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
1998
Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer
2001
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
1996
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Ablative Radioactive Iodine Therapy for Apparently Localized Thyroid Carcinoma: A Decision Analytic Perspective
1990
Thyroid Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations
1996
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
2006
Morbidity and mortality in follicular thyroid cancer.
1995
Medullary Thyroid Carcinoma
1998
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
2000
Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands
1988
External radiotherapy in thyroid cancers
1985
Embolization for Vertebral Metastases of Follicular Thyroid Carcinoma
2000 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
1993
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
Multifactorial analysis of survival in thyroid cancer: Pitfalls of applying the results of published studies to another population
1986
Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
1996
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene
1998
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*
2000
Preoperative Staging of Papillary Thyroid Carcinoma: Comparison of Ultrasound Imaging and CT
2009
Cushing’s Syndrome Due to Medullary Thyroid Carcinoma: Diagnosis by Proopiomelanocortin Messenger Ribonucleic Acid in Situ Hybridization
2003
Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation?
2002
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy.
1992
Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid
2001
Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
1995
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
2011
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
1995
Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
1994
Preoperative Prediction of Central Lymph Node Metastasis in Thyroid Papillary Microcarcinoma Using Clinicopathologic and Sonographic Features
2012
Procalcitonin: A Marker for the Diagnosis and Follow-Up of Patients with Medullary Thyroid Carcinoma
2008
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma
2011
Latent Subclinical Medullary Thyroid Carcinoma: Diagnosis and Treatment
1998
Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
2012
Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
1995
Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer: Towards A Selective Approach
1998
Papillary Thyroid Carcinoma
1990
Clinicopathological Characteristics and Long‐term Outcome in Patients with Distant Metastases from Differentiated Thyroid Cancer
2006
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas
2001
Current status and performance goals for serum thyroglobulin assays
1996
Cancer treatment and survivorship statistics, 2019
2019 Standout
Airway stenting for the treatment of laryngotracheal stenosis secondary to thyroid cancer
2008
Approach to the Thyroid Cancer Patient with Bone Metastases
2011
The Role of Radiation Therapy in the Treatment of Medullary Thyroid Cancer
2010
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
2008
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
2005
Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age
1986
Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma
1998
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
2002
Impact of Initial Surgical Treatment on Survival of Patients with Differentiated Thyroid Cancer: Experience of an Endocrine Surgery Center in an Iodine‐deficient Region
2000
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
1994
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
2004
Differentiated Thyroid Cancer: “Complete” Rational Approach
2000
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
1988
Guidelines for the management of thyroid cancer
2014 Standout
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
2004
Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
1990
Incidence of Regional Recurrence Guiding Radicality in Differentiated Thyroid Carcinoma
1996
Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway.
1991
Papillary thyroid carcinoma: factors influencing prognosis and current therapy.
1987
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome
1986
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
2006
Procalcitonin as an Acute Phase Marker
2001
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
2008
RET Proto-Oncogene in the Development of Human Cancer
1999
Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma
1998
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
2011
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
2007
Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors
2004
The Relationship between the Expression of MHC Class II Antigens and the Clinical Prognosis of Papillary Thyroid Carcinoma Patients
2007
Thyroid carcinoma
2003 Standout
Central lymph node metastases in unilateral papillary thyroid microcarcinoma
2009
Evidence‐based Approach to the Management of Sporadic Medullary Thyroid Carcinoma
2007
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Total Versus Subtotal Thyroidectomy
1990
Works of P Gardet being referenced
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
1996
Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families
1995
Screening for adrenal medullary disease in patients with medullary thyroid carcinoma
1994
A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients
1991
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma
1994
Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies
1988
Cushing’s syndrome in medullary thyroid carcinoma
1995
Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases
1992
Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma
1989
Study of Calcitonin and Thyroglobulin Gene Expression in Human Mixed Follicular and Medullary Thyroid Carcinoma
1991
Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer: A French cooperative study
1987
Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif
1988
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
1985
Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid Carcinoma
1986
[Ultrasonographic aspects of hepatic metastases of thyroid medullary cancers].
1996
[Role of radiotherapy in the treatment of medullary cancer of the thyroid].
1984
[Medullary thyroid cancers. Prognostic factors of nonassociated sporadic forms. Therapeutic implications].
1984
Relationship between Thyrotropin Stimulation and Radioiodine Uptake in Lung Metastases of Differentiated Thyroid Carcinoma
1983
Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.
1989
Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
1989
Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy
1990
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
1996
Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
1989